This is what the appeal trials will cost for Lundbeck
Lundbeck has decided to appeal the historical fine of DKK 700m (USD 124m) that the company has been handed by the EU Commission. That manoeuvre will run the company far less than the massive fine.
by Benjamin Werner Christensen
Trial costs for what is likely to be two separate appeal trials will be a costly affair for the Danish pharmaceutical company – the question is; how costly?
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
